Evidence map›Paper›PMID 32832657›Full record

ArticleScience advances2020

Epigenetically heterogeneous tumor cells direct collective invasion through filopodia-driven fibronectin micropatterning.

Emily R Summerbell, Janna K Mouw, Joshua S K Bell, Christina M Knippler, Brian Pedro, Jamie L Arnst, Tala O Khatib, Rachel Commander, Benjamin G Barwick, Jessica Konen and 5 more

Open access · goldAbstract read
In one paragraph

Article in Science advances, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 48 papers.

0numbers the graph read from it
0cells of the map it votes in
48citing papers in PubMed
4.9field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

48 citing papers in PubMed, 82 citations in OpenAlex.

  1. FASEB bioAdvances · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Collective migration modes in development, tissue repair and cancer.Nature reviews. Molecular cell biology · 2025
    Review
  8. Aquaporin 5 expression regulates MDA-MB-231 spheroid multicellular invasion.American journal of physiology. Cell physiology · 2025
    Article
  9. Review
  10. Filopodia numbers impact chemotactic migration speed.bioRxiv : the preprint server for biology · 2025
    Article
  11. Article
  12. Article
  13. Article
  14. The role and regulation of integrins in cell migration and invasion.Nature reviews. Molecular cell biology · 2025
    Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 1 institution in 1 country.

Emily R SummerbellGraduate Program in Cancer Biology, Emory University, Atlanta, GA, USA.ORCID 0000-0002-1336-1433
Janna K MouwDepartment of Hematology and Medical Oncology, Emory University, Atlanta, GA, USA.ORCID 0000-0002-9846-8466
Joshua S K BellGraduate Program in Genetics and Molecular Biology, Emory University, Atlanta, GA, USA.
Christina M KnipplerDepartment of Hematology and Medical Oncology, Emory University, Atlanta, GA, USA.
Brian PedroGraduate Program in Cancer Biology, Emory University, Atlanta, GA, USA.ORCID 0000-0003-1898-3458
Jamie L ArnstDepartment of Hematology and Medical Oncology, Emory University, Atlanta, GA, USA.
Tala O KhatibGraduate Program in Biochemistry, Cell and Developmental Biology, Emory University, Atlanta, GA, USA.
Rachel CommanderGraduate Program in Cancer Biology, Emory University, Atlanta, GA, USA.
Benjamin G BarwickDepartment of Hematology and Medical Oncology, Emory University, Atlanta, GA, USA.ORCID 0000-0001-9810-3566
Jessica KonenGraduate Program in Cancer Biology, Emory University, Atlanta, GA, USA.
Bhakti DwivediWinship Cancer Institute, Emory University, Atlanta, GA, USA.
Sandra SebyWinship Cancer Institute, Emory University, Atlanta, GA, USA.
Jeanne KowalskiWinship Cancer Institute, Emory University, Atlanta, GA, USA.ORCID 0000-0003-3458-3024
Paula M VertinoWinship Cancer Institute, Emory University, Atlanta, GA, USA.
Adam I MarcusDepartment of Hematology and Medical Oncology, Emory University, Atlanta, GA, USA.ORCID 0000-0003-0484-3569
Emory University · US

Funding

Winship Cancer Institute Cancer Center Support GrantP30CA138292 · NCI · EMORY UNIVERSITY · PI Suresh S Ramalingam · 2009 to 2026
$47.5M
MEDICAL SCIENTIST TRAINING PROGRAMT32GM008169 · NIGMS · EMORY UNIVERSITY · PI GROSS, ROBERT E · 1987 to 2021
$20.3M
Systems analysis of phenotypic switch in control of cancer invasionU54CA209992 · NCI · YALE UNIVERSITY · PI LEVCHENKO, ANDRE · 2016 to 2021
$10.1M
Developing a pharmacologic approach to treat LKB1 mutant NSCLC patientsR01CA194027 · NCI · EMORY UNIVERSITY · PI GILBERT-ROSS, MELISSA, MARCUS, ADAM I. · 2016 to 2020
$2.5M
Atypical Angiogenic Mimicry During Collective Lung Cancer InvasionR01CA236369 · NCI · EMORY UNIVERSITY · PI MARCUS, ADAM I. · 2019 to 2023
$1.8M
Deconstructing the collective invasion pack to define Myo10 functionR01CA250422 · NCI · EMORY UNIVERSITY · PI MARCUS, ADAM I. · 2020 to 2024
$1.8M
Genomic and molecular dissection of the collective invasion packR21CA201744 · NCI · EMORY UNIVERSITY · PI MARCUS, ADAM I. · 2016 to 2017
$373k
Defining cell-cell cooperativity between phenotypically heterogeneous invading cancer cellsF31CA210601 · NCI · EMORY UNIVERSITY · PI SUMMERBELL, EMILY · 2016 to 2018
$132k
DNA demethylation and the reprogramming of transcriptional dynamicsF31CA186676 · NCI · EMORY UNIVERSITY · PI BELL, JOSHUA STEVEN · 2014 to 2016
$129k
Defining an LKB1-regulated motility switch in cancer cell invasion and metastasisF31CA180511 · NCI · EMORY UNIVERSITY · PI KONEN, JESSICA · 2014 to 2016
$118k
Defining leader cell biology in collective invasionF31CA225049 · NCI · EMORY UNIVERSITY · PI PEDRO, BRIAN ARAM · 2018 to 2020
$108k
NCI NIH HHS F31 CA180511NCI NIH HHS F31 CA186676NCI NIH HHS F31 CA210601NCI NIH HHS F31 CA225049NCI NIH HHS P30 CA138292NCI NIH HHS R01 CA194027NCI NIH HHS R01 CA236369NCI NIH HHS R01 CA250422NCI NIH HHS R21 CA201744NCI NIH HHS U54 CA209992NIGMS NIH HHS T32 GM008169
6 · The paper itself

Abstract

Tumor heterogeneity drives disease progression, treatment resistance, and patient relapse, yet remains largely underexplored in invasion and metastasis. Here, we investigated heterogeneity within collective cancer invasion by integrating DNA methylation and gene expression analysis in rare purified lung cancer leader and follower cells. Our results showed global DNA methylation rewiring in leader cells and revealed the filopodial motor

Identifiers

PMID32832657
PMCPMC7439406
OpenAlexW3043997843

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.